AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34960106 — intervention group
Group type: COMPARATOR
Intervention: Cyclodextrins for vitamin D3
Number of subjects: 75
Study 34960106 — intervention group
Group type: COMPARATOR
Intervention: Cyclodextrins for vitamin E
Number of subjects: 75
Study 32481287 — intervention group
Group type: EXPERIMENTAL
Intervention: Dan-Hong Hua-Yu oral solution
Number of subjects: 64
Study 32481287 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 64
Study 34490600 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based emotional regulation (face-to-face)
Number of subjects: 96
Study 34490600 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based emotional regulation (via mobile app)
Number of subjects: 96
Study 34490600 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 96
Study 33607978 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma group (AG)
Number of subjects: 77
Study 33607978 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 77
Study 33607978 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma group (AG) - mild
Number of subjects: 77
Study 33607978 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma group (AG) - severe
Number of subjects: 77
Study 32972315 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg twice daily
Number of subjects: 112
Study 32972315 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (dose-adjusted)
Number of subjects: 112
Study 32996594 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate bleeding on probing (BOP) (<10% bleeding sites)
Number of subjects: 3478
Study 32996594 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to severe periodontitis
Number of subjects: 3478
Study 32996594 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to severe periodontitis in females
Number of subjects: 3478
Study 32996594 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to severe periodontitis in overweight or obese individuals
Number of subjects: 3478
Study 32996594 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to severe periodontitis in individuals with cardiometabolic comorbidities
Number of subjects: 3478
Study 33304875 — intervention group
Group type: EXPERIMENTAL
Intervention: Irie Homes Toolbox
Number of subjects: 0
Study 32600499 — intervention group
Group type: EXPERIMENTAL
Intervention: WM-T
Number of subjects: 98
Study 32600499 — intervention group
Group type: EXPERIMENTAL
Intervention: EWM-T
Number of subjects: 98
Study 32600499 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 98
Study 34284374 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% Sodium fluoride varnish (NaFV) applied at 3-month intervals
Number of subjects: 323
Study 34284374 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer sealant (GIS) - single placement
Number of subjects: 323
Study 34284374 — intervention group
Group type: COMPARATOR
Intervention: Glass ionomer sealant (GIS)
Number of subjects: 323
Study 35466808 — intervention group
Group type: EXPERIMENTAL
Intervention: Dressings with Syzygium cumini extract (SHG)
Number of subjects: 90
Study 35466808 — intervention group
Group type: COMPARATOR
Intervention: Standard hydrocolloid gel dressings (HG)
Number of subjects: 90
Study 34619515 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-curing Refobacin® Plus Bone Cement (RP)
Number of subjects: 54
Study 34619515 — intervention group
Group type: COMPARATOR
Intervention: Normal-curing Refobacin® Bone Cement R (RR)
Number of subjects: 54
Study 34619515 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (RP and RR)
Number of subjects: 54
Study 35238798 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIE + MLT (3 mg)
Number of subjects: 23
Study 34688568 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticision-assisted orthodontic treatment (CORT); n=26 (6 males, 20 females, mean age 21.30)
Number of subjects: 52
Study 34688568 — intervention group
Group type: COMPARATOR
Intervention: Traditional orthodontic treatment (TRAD); n=26 (8 males, 18 females, mean age 21.46)
Number of subjects: 52
Study 34688568 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticision-assisted orthodontic treatment (CORT)
Number of subjects: 52
Study 34688568 — intervention group
Group type: COMPARATOR
Intervention: Traditional orthodontic treatment (TRAD)
Number of subjects: 52
Study 34364917 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (5 μg/kg daily for the first 5 days and every third day thereafter until day 26) plus standard medical therapy (SMT)
Number of subjects: 176
Study 34364917 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (SMT) alone
Number of subjects: 176
Study 34364917 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (5 μg/kg daily for the first 5 days and every third day thereafter until day 26) plus SMT
Number of subjects: 176
Study 33263263 — intervention group
Group type: EXPERIMENTAL
Intervention: Anacetrapib
Number of subjects: 574
Study 34100976 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) therapy
Number of subjects: 0
Study 34100976 — intervention group
Group type: COMPARATOR
Intervention: PEMF therapy
Number of subjects: 0
Study 33444874 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluency shaping treatment (soft voice onsets)
Number of subjects: 119
Study 33444874 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 119
Study 33587856 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage Therapy (MT)
Number of subjects: 60
Study 33587856 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal Hypopressive Gymnastics (AHG)
Number of subjects: 60
Study 33587856 — intervention group
Group type: EXPERIMENTAL
Intervention: MT + AHG
Number of subjects: 60
Study 33587856 — intervention group
Group type: COMPARATOR
Intervention: Control (MT and AHG individually)
Number of subjects: 60
Study 33781130 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 120
Study 33781130 — intervention group
Group type: COMPARATOR
Intervention: Noninvasive positive-pressure ventilation (NPPV)
Number of subjects: 120
Study 32736893 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg/day for 7 days
Number of subjects: 20
Study 32736893 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg/day for 7 days
Number of subjects: 20
Study 32736893 — intervention group
Group type: COMPARATOR
Intervention: Control (PBS)
Number of subjects: 20
Study 35780637 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip abductor strengthening (HABG)
Number of subjects: 66
Study 35780637 — intervention group
Group type: COMPARATOR
Intervention: Hip adductor strengthening (HADG)
Number of subjects: 66
Study 33161005 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training
Number of subjects: 39
Study 33161005 — intervention group
Group type: COMPARATOR
Intervention: Conventional balance exercises
Number of subjects: 39
Study 34579060 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised exercise and nutrition intervention
Number of subjects: 175
Study 34579060 — intervention group
Group type: COMPARATOR
Intervention: Attention-control group
Number of subjects: 175
Study 33689641 — intervention group
Group type: EXPERIMENTAL
Intervention: CT‐1P Non‐Contact Tonometer (NCT)
Number of subjects: 41
Study 33689641 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsair IntelliPuff
Number of subjects: 41
Study 33689641 — intervention group
Group type: EXPERIMENTAL
Intervention: Icare rebound tonometer
Number of subjects: 41
Study 33689641 — intervention group
Group type: COMPARATOR
Intervention: Goldmann Applanation Tonometry (GAT)
Number of subjects: 41
Study 33689641 — intervention group
Group type: EXPERIMENTAL
Intervention: Central Corneal Thickness (CCT) association
Number of subjects: 41
Study 32070680 — intervention group
Group type: EXPERIMENTAL
Intervention: Tdap
Number of subjects: 129
Study 32070680 — intervention group
Group type: COMPARATOR
Intervention: Td
Number of subjects: 129
Study 34488658 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled arterial hypotension (CAH) achieved by urapidil and/or increased anaesthetic depth
Number of subjects: 56
Study 34488658 — intervention group
Group type: COMPARATOR
Intervention: No controlled arterial hypotension (control group)
Number of subjects: 56
Study 32620144 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-short-wave diathermy treatment + nationally recommended standard medical treatment
Number of subjects: 410
Study 32620144 — intervention group
Group type: COMPARATOR
Intervention: Nationally recommended standard medical treatment
Number of subjects: 410
Study 35662337 — intervention group
Group type: EXPERIMENTAL
Intervention: Mezlocillin 50 mg/kg q12h
Number of subjects: 48
Study 35662337 — intervention group
Group type: EXPERIMENTAL
Intervention: Mezlocillin 20 mg/kg q8h
Number of subjects: 48
Study 33846214 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framed messaging
Number of subjects: 365
Study 33846214 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed messaging
Number of subjects: 365
Study 36462182 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (high-dose vitamin D3)
Number of subjects: 21315
Study 36462182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21315
Study 36462182 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (high-dose vitamin D3) in those taking antidepressants at baseline
Number of subjects: 21315
Study 36462182 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (high-dose vitamin D3) in participants with predicted 25(OH)D concentration <50 nmol/L
Number of subjects: 21315
Study 36462182 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (high-dose vitamin D3) in participants with predicted 25(OH)D ≥50 nmol/L
Number of subjects: 21315
Study 32900220 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated treatment (cognitive behavioural treatment and motivational enhancement)
Number of subjects: 117
Study 32900220 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (alcohol-focused treatment)
Number of subjects: 117
Study 32900220 — intervention group
Group type: COMPARATOR
Intervention: Both treatments (Integrated and Control)
Number of subjects: 117
Study 32444629 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadratus Lumborum Block (QL block)
Number of subjects: 46
Study 32444629 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia
Number of subjects: 46
Study 35665689 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based HIV counselling and testing (HB-HCT)
Number of subjects: 0
Study 33725772 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiviral medications
Number of subjects: 65
Study 33725772 — intervention group
Group type: COMPARATOR
Intervention: Moderate COVID-19 patients
Number of subjects: 65
Study 33725772 — intervention group
Group type: COMPARATOR
Intervention: Severe COVID-19 patients
Number of subjects: 65
Study 33725772 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 65
Study 33725772 — intervention group
Group type: COMPARATOR
Intervention: Non-anxiety patients
Number of subjects: 65
Study 33725772 — intervention group
Group type: COMPARATOR
Intervention: Non-depression patients
Number of subjects: 65
Study 35809774 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 43
Study 35809774 — intervention group
Group type: COMPARATOR
Intervention: Phenoxybenzamine
Number of subjects: 43
Study 35770564 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure on HT7 and Yintang points for 30 minutes (5 minutes each point)
Number of subjects: 100
Study 34973904 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1800
Study 34973904 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1800
Study 34973904 — intervention group
Group type: COMPARATOR
Intervention: Patients without HCLs
Number of subjects: 1800
Study 34973904 — intervention group
Group type: COMPARATOR
Intervention: Patients with HCLs
Number of subjects: 1800
Study 34973904 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with HCLs undergoing PCI
Number of subjects: 1800
Study 34973904 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with HCLs undergoing CABG
Number of subjects: 1800
Study 33405313 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive imagery task (past-positive imagery condition)
Number of subjects: 38
Study 33405313 — intervention group
Group type: EXPERIMENTAL
Intervention: Future-negative task
Number of subjects: 38
Study 35881986 — intervention group
Group type: EXPERIMENTAL
Intervention: lifestyle intervention
Number of subjects: 0
Study 35881986 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 adaptations
Number of subjects: 0
Study 34383010 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative prednisolone plus NSAID (ketorolac)
Number of subjects: 470
Study 34383010 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative prednisolone plus NSAID (ketorolac)
Number of subjects: 470
Study 34383010 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative NSAID (ketorolac)
Number of subjects: 470
Study 34383010 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative NSAID (ketorolac)
Number of subjects: 470
Study 34383010 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-Tenon dexamethasone depot
Number of subjects: 470
Study 35661036 — intervention group
Group type: EXPERIMENTAL
Intervention: ISP without an insertion of Essix retainer (Group I)
Number of subjects: 40
Study 35661036 — intervention group
Group type: EXPERIMENTAL
Intervention: ISP with an insertion of Essix retainer (Group II)
Number of subjects: 40
Study 35661036 — intervention group
Group type: COMPARATOR
Intervention: Control groups (Subgroup A and C)
Number of subjects: 40
Study 33829664 — intervention group
Group type: EXPERIMENTAL
Intervention: Front-of-package alone
Number of subjects: 1603
Study 33829664 — intervention group
Group type: EXPERIMENTAL
Intervention: Front-of-package plus nutrition/ingredient information
Number of subjects: 1603
Study 33829664 — intervention group
Group type: EXPERIMENTAL
Intervention: Statement of identity terms
Number of subjects: 1603
Study 35311677 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Integrator app with additional coach support
Number of subjects: 205
Study 35311677 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Integrator app only
Number of subjects: 205
Study 35311677 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 205
Study 35311677 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention groups
Number of subjects: 205
Study 34810175 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 0
Study 34810175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33558988 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia (0.130 FiO2) with placebo ingestion
Number of subjects: 11
Study 33558988 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoxia with 13 mmol nitrate ingestion
Number of subjects: 11
Study 33558988 — intervention group
Group type: COMPARATOR
Intervention: Normoxia with placebo ingestion
Number of subjects: 11
Study 33558988 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia with nitrate ingestion
Number of subjects: 11
Study 32068102 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation of questions in surveys
Number of subjects: 180
Study 32068102 — intervention group
Group type: COMPARATOR
Intervention: Response rates and number of respondents
Number of subjects: 180
Study 32068102 — intervention group
Group type: COMPARATOR
Intervention: Journal impact factor
Number of subjects: 180
Study 34911703 — intervention group
Group type: EXPERIMENTAL
Intervention: Escape room themed around acute management of sepsis (n=133)
Number of subjects: 262
Study 34911703 — intervention group
Group type: COMPARATOR
Intervention: General acute care escape room (n=129)
Number of subjects: 262
Study 34911703 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (n=262)
Number of subjects: 262
Study 33314521 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical plication (VP) of the rectovaginal septum
Number of subjects: 40
Study 33314521 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal plication (HP) of the rectovaginal septum
Number of subjects: 40
Study 35788739 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled ginger essential oil
Number of subjects: 248
Study 35788739 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled German chamomile essential oil
Number of subjects: 248
Study 35788739 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled bergamot essential oil
Number of subjects: 248
Study 35788739 — intervention group
Group type: COMPARATOR
Intervention: Odorless control oil
Number of subjects: 248
Study 34276432 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive home visiting program by PMI nurses (12 visits in the first year, 6 in the second year, and 4 in the third and fourth years)
Number of subjects: 64
Study 34276432 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive home visiting program by PMI nurses
Number of subjects: 64
Study 32741496 — intervention group
Group type: COMPARATOR
Intervention: 0 booster calls
Number of subjects: 427
Study 32741496 — intervention group
Group type: COMPARATOR
Intervention: 1 booster call
Number of subjects: 427
Study 32741496 — intervention group
Group type: COMPARATOR
Intervention: 2 booster calls
Number of subjects: 427
Study 35007306 — intervention group
Group type: EXPERIMENTAL
Intervention: DCXR-CAD plus urine FujiLAM plus usual care
Number of subjects: 0
Study 35007306 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 0
Study 35638561 — intervention group
Group type: EXPERIMENTAL
Intervention: CJM112 300 mg (anti-IL-17A IgG1/κ monoclonal antibody)
Number of subjects: 66
Study 35897357 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute moderate-intensity treadmill exercise lasting for 30 min at 45−68% heart rate reserve (HRR) with background music
Number of subjects: 60
Study 35897357 — intervention group
Group type: COMPARATOR
Intervention: Listening to the same music for 40 min without any exercise (Control group)
Number of subjects: 60
Study 33531176 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial-Pivot TKA
Number of subjects: 88
Study 33531176 — intervention group
Group type: COMPARATOR
Intervention: Posterior-Stabilized TKA
Number of subjects: 88
Study 32795364 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Health First Aid (MHFA) intervention provided by Mental Health First Aid England (MHFAE)
Number of subjects: 800
Study 32795364 — intervention group
Group type: COMPARATOR
Intervention: Brief consultation from MHFAE on promoting mental health and well-being in the workplace
Number of subjects: 800
Study 36467553 — intervention group
Group type: EXPERIMENTAL
Intervention: Zaoren Anshen capsule and 5 mg zolpidem tartrate (Group ZA + Z5)
Number of subjects: 131
Study 36467553 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg zolpidem tartrate (Group Z10)
Number of subjects: 131
Study 36467553 — intervention group
Group type: COMPARATOR
Intervention: 5 mg zolpidem tartrate and placebo capsule (Group Z5)
Number of subjects: 131
Study 36467553 — intervention group
Group type: COMPARATOR
Intervention: Zaoren Anshen capsule and placebo pill (Group ZA)
Number of subjects: 131
Study 34052844 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic compounds (4 strains; Lactobacillus plantarum MH‐301, L. rhamnosus LGG‐18, L. acidophilus, Bifidobacterium animalis subsp.lactis LPL‐RH)
Number of subjects: 0
Study 34052844 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic compounds administration in rat models
Number of subjects: 0
Study 32126581 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient cervical ripening with transcervical Foley's catheter
Number of subjects: 129
Study 32126581 — intervention group
Group type: COMPARATOR
Intervention: Inpatient cervical ripening with transcervical Foley's catheter
Number of subjects: 129
Study 32386395 — intervention group
Group type: EXPERIMENTAL
Intervention: THC (7.5 and/or 15 mg oral)
Number of subjects: 23
Study 32386395 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 34792264 — intervention group
Group type: EXPERIMENTAL
Intervention: FFED + AAF (n=21)
Number of subjects: 41
Study 34792264 — intervention group
Group type: COMPARATOR
Intervention: FFED (n=20)
Number of subjects: 41
Study 34792264 — intervention group
Group type: EXPERIMENTAL
Intervention: FFED + AAF
Number of subjects: 41
Study 34792264 — intervention group
Group type: COMPARATOR
Intervention: FFED
Number of subjects: 41
Study 33197388 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically instrumented one-SD shorter telomere length
Number of subjects: 1369
Study 33197388 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of two-sample mendelian randomisation results
Number of subjects: 1369
Study 35460517 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management intervention for lung cancer surgery preparation/recovery
Number of subjects: 41
Study 33038967 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous vosoritide therapy
Number of subjects: 0
Study 33038967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34219361 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (45 mg/d)
Number of subjects: 55
Study 34219361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 34219361 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 55
Study 36314122 — intervention group
Group type: EXPERIMENTAL
Intervention: RT+CR+AT
Number of subjects: 88
Study 36314122 — intervention group
Group type: COMPARATOR
Intervention: CR+AT
Number of subjects: 88
Study 33864354 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium + Vitamin B6 (Magne B6®; daily dose 300 mg magnesium and 30 mg vitamin B6)
Number of subjects: 0
Study 33864354 — intervention group
Group type: COMPARATOR
Intervention: Magnesium alone (Magnespasmyl®; daily dose 300 mg)
Number of subjects: 0
Study 32372561 — intervention group
Group type: EXPERIMENTAL
Intervention: Local methylcobalamin injection and lidocaine (LM group)
Number of subjects: 105
Study 32372561 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular methylcobalamin and local lidocaine (IM group)
Number of subjects: 105